COO

Cooper Companies (The)

COO · Salud · Next earnings: 09 Sep 2026 · After the close · Q3 2026

Relevance 38/100 · Minor

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.

Sector Healthcare · Medical Instruments & Supplies
Website https://www.coopercos.com

What the market expects

ConsensusPrior-year EPS

EPS1.121.10

Revenue1,098,248,680—

15 analysts

How expectations have moved

Expectations: Neutral

Expectativas neutrales: cotiza un 23% por debajo de su máximo de 52 semanas.

Stock, 90 days: +15.9%

Prior behaviour

Average absolute move: 1.7%
Largest move: 2.8%
releases with a move larger than 5%: 0%
beat the EPS consensus in: 4 of the last 4

Quarter Date 1-session move Surprise EPS

Apr 2026 04 Jun 2026 +2.8% +10.0%

Jan 2026 05 Mar 2026 -2.2% +6.8%

Oct 2025 04 Dec 2025 +1.4% +3.6%

Jul 2025 27 Aug 2025 +0.6% +2.8%

Historical moves describe typical magnitude, not a future direction.

Expected move

±1.7% (historical)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price: 70.96
30 days: -1.5%
90 days: +15.9%
Distance to 52-week high: -21.0%
Market cap: 13,776,963,600

Metrics to watch

El trimestre anterior batió el consenso de BPA un 10%.
Ventas del fármaco o producto principal
Guidance de ingresos anual
Avances de pipeline / ensayos clínicos mencionados
Margen operativo
BPA e ingresos frente al consenso (sorpresa)
Cambio en el guidance respecto al trimestre anterior
Reacción del mercado frente al movimiento histórico y al implícito

Relevance breakdown

market_cap: 5.8
analyst_coverage: 6.0
estimate_revisions: 6.3
recent_price_move: 2.8
historical_earnings_vol: 2.6
sector_importance: 4.0
recent_news_coverage: 7.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.